Net Cash Provided by (Used in) Operating Activities |
-3.46M |
USD |
-11.2% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
0 |
USD |
-100% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
-88K |
USD |
|
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
100M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Common Stock, Shares, Issued |
26.6M |
shares |
+2.2% |
Q2 2024 |
Q2 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-3.55M |
USD |
-36.4% |
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
9.21M |
USD |
-47.1% |
Q2 2024 |
Q2 2024 |
Deferred Tax Assets, Valuation Allowance |
9.09M |
USD |
+50.3% |
Q4 2023 |
FY 2023 |
Deferred Tax Assets, Gross |
9.09M |
USD |
+50.3% |
Q4 2023 |
FY 2023 |
Payments to Acquire Property, Plant, and Equipment |
88K |
USD |
|
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
5.8M |
USD |
+40.9% |
Q4 2023 |
FY 2023 |
Preferred Stock, Shares Authorized |
10M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Unrecognized Tax Benefits |
287K |
USD |
+61% |
Q4 2023 |
FY 2023 |
Additional Paid in Capital |
55.1M |
USD |
+9.01% |
Q2 2024 |
Q2 2024 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2024 |
Q2 2024 |
Share-based Payment Arrangement, Expense |
4.36M |
USD |
+143% |
Q2 2024 |
Q2 2024 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |